Clinical association | Variable | Hazards ratio | 95 % Confidence interval | p value |
---|---|---|---|---|
Metastasis-free survival | ||||
PSME1 high nuclear expression | 3.685 | 1.177–11.541 | 0.025* | |
Histological grade | 1.831 | 0.710–4.723 | 0.211 | |
Age | 0.974 | 0.932–1.017 | 0.225 | |
Gender (M) | 0.377 | 0.070–2.039 | 0.257 | |
Event-free survival | ||||
PSME1 high nuclear expression | 2.667 | 0.919–7.743 | 0.071 | |
Histological grade | 2.216 | 0.882–5.569 | 0.090 | |
Age | 0.975 | 0.937–1.015 | 0.215 | |
Gender (M) | 0.339 | 0.068–1.695 | 0.188 | |
Overall survival | ||||
PSME1 high nuclear expression | 2.612 | 0.916–7.448 | 0.072 | |
Histological grade | 2.552 | 0.953–6.837 | 0.062 | |
Age | 1.005 | 0.972–1.039 | 0.758 | |
Gender (M) | 2.071 | 0.660–6.502 | 0.212 |